AbbVie : ABBV

All AbbVie Articles

583 Articles

Lee Jackson | Jan 24, 2020 at 6:40 AM EST

5 Top Income Stocks That Could Soar in 2020 as Interest Rates Plunge

These five stock income ideas are rated Buy by major Wall Street firms and offer consistent and dependable dividends. They…

Chris Lange | Jan 19, 2020 at 7:05 AM EST

American Airlines, Netflix, Starbucks and More Major Earnings This Week

24/7 Wall St. has put together a preview of AbbVie, American Airlines, Netflix, Starbucks and some of the other most…

Chris Lange | Jan 13, 2020 at 9:40 AM EST

Short Sellers Shy Away From Big Pharma

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Dec 26, 2019 at 8:55 AM EST

Big Pharma Short Sellers Get Selective

The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Paul Ausick | Dec 24, 2019 at 7:55 AM EST

Allergan Gets FDA Approval for Migraine Treatment

The FDA has approved Allergan's treatment for migraines in adults. The drug is the first of its class to obtain…

Chris Lange | Dec 11, 2019 at 9:45 AM EST

Big Pharma Short Sellers Grow More Selective

The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Nov 27, 2019 at 9:00 AM EST

Big Pharma Short Sellers Hike Their Bets

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 19, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack…

Trey Thoelcke | Nov 18, 2019 at 7:45 AM EST

AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses

Here are five health-care-related stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross.

Chris Lange | Nov 12, 2019 at 8:50 AM EST

Big Pharma Scares Off Short Sellers

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 27, 2019 at 6:55 AM EDT

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

24/7 Wall St. has put together a preview of AT&T, Facebook, T-Mobile and the other most prominent earnings reports due…

Chris Lange | Oct 25, 2019 at 9:59 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Oct 15, 2019 at 6:35 AM EDT

20 Dividend Stocks for All Baby Boomers to Retire On

Here are 20 companies that should offer investors who are retired or near retirement some added income to help make…

Chris Lange | Oct 14, 2019 at 10:05 AM EDT

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan has finally announced that its shareholders have voted to approve the company’s acquisition of AbbVie. The acquisition is expected…

Chris Lange | Oct 10, 2019 at 9:40 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The September 30 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 14 15 16 17 18 … 39

AbbVie : ABBV

All AbbVie Articles

5 Top Income Stocks That Could Soar in 2020 as Interest Rates Plunge

American Airlines, Netflix, Starbucks and More Major Earnings This Week

Short Sellers Shy Away From Big Pharma

Big Pharma Short Sellers Get Selective

Allergan Gets FDA Approval for Migraine Treatment

Big Pharma Short Sellers Grow More Selective

Big Pharma Short Sellers Hike Their Bets

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses

Big Pharma Scares Off Short Sellers

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

Short Sellers Can’t Make Up Their Minds on Big Pharma

20 Dividend Stocks for All Baby Boomers to Retire On

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Big Pharma Sees Rising Tide in Short Interest

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

AbbVie : ABBV

All AbbVie Articles

5 Top Income Stocks That Could Soar in 2020 as Interest Rates Plunge

American Airlines, Netflix, Starbucks and More Major Earnings This Week

Short Sellers Shy Away From Big Pharma

Big Pharma Short Sellers Get Selective

Allergan Gets FDA Approval for Migraine Treatment

Big Pharma Short Sellers Grow More Selective

Big Pharma Short Sellers Hike Their Bets

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses

Big Pharma Scares Off Short Sellers

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

Short Sellers Can’t Make Up Their Minds on Big Pharma

20 Dividend Stocks for All Baby Boomers to Retire On

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Big Pharma Sees Rising Tide in Short Interest

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation